Announcements Trials
Browse Landscape

Phase

Phase NA 1

Status

Terminated 1

Sponsor Class

INDIV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Uterine Cervical Neoplasms 1Uterine Cervical Dysplasia 1Neoplasms 1Laryngeal Diseases 1Head and Neck Neoplasms 1Carcinoma, Squamous Cell 1

Interventions

Cisplatin 4Cetuximab 4Pemetrexed 3N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Gemcitabine 2pembrolizumab 1monalizumab 1durvalumab 1X-Rays 1Vitamin B 12 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Radiation 1Proflavine 1Paclitaxel 1Modafinil 1Minocycline 1Metformin 1Gefitinib 1Gabapentin 1Folic Acid 1Fibroblast Growth Factor 7 1Drug Therapy 1Docetaxel 1Chemical Fractionation 1Carboplatin 1Bupropion 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Laryngeal Diseases × Proflavine × Clear all
NCT01456143 2018-02-01

Optical Imaging of Head and Neck Cancer

Anandasabapathy, Sharmila, M.D.

Phase NA Terminated
33 enrolled 9 charts
Head & Neck

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Laryngeal Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡